Certification Rate
99.2%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Tarrytown, NY NAICS: 54171
U.S. Department of Labor's OFLC discloses 713 Labor Condition Application filings naming Regeneron Pharmaceuticals, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 1,044 H-1B petitions naming Regeneron Pharmaceuticals, Inc. through FY2024, and approved nearly every one of them: 99.4% approved (1,038 approvals, 6 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Regeneron Pharmaceuticals, Inc. is listed in 713 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 99.2% of those LCAs; the median listed offered wage is $153,437. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Tarrytown, NY.
Regeneron Pharmaceuticals, Inc. LCA outcome mix
713DOL LCA filings on record
Regeneron Pharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
713 294th of 122824 higher than 122,530 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $69,680–$450,440 .
DOL LCA release change
Regeneron Pharmaceuticals, Inc. has filed 713 LCAs (more volume than 100% of U.S. employer filers in this extract). DOL certification: 99.2%. Worksites span 3 states , led by NY.
On 712 LCAs with comparable offered vs prevailing wages, Regeneron Pharmaceuticals, Inc. averages about 31.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (56.9% of LCA filings).
Certification Rate
99.2%
Very high DOL cert
Avg. Salary
$153,437
Well above portal avg
Total Workers
1,241
Large worker count
Regeneron Pharmaceuticals, Inc. vs a peer vs the national average, from DOL LCA data.
145 completed-year filings in FY2023, 159 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Compensation range for H-1B positions at Regeneron Pharmaceuticals, Inc.
H-1B LCA filing trends from FY2023 to FY2026
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Most frequently listed job titles at Regeneron Pharmaceuticals, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Scientist | 51 | $137,981 |
| Principal Scientist | 40 | $160,255 |
| Associate Scientist | 25 | $88,466 |
| Sr Scientist | 21 | $143,670 |
| Scientist | 19 | $118,284 |
| Principal Biostatistician | 17 | $147,573 |
| Postdoctoral Fellow | 15 | $95,574 |
| Principal Statistical Programmer | 14 | $146,656 |
| Staff Engineer | 13 | $155,527 |
| Senior Associate Scientist | 13 | $100,429 |
| Sr Mgr Statistical Programming | 9 | $190,027 |
| Sr Statistical Programmer | 8 | $126,220 |
| Sr Assoc Scientist | 8 | $99,333 |
| Mgr Statistical Programming | 8 | $166,031 |
| Mgr Biostatistics | 8 | $162,239 |
Where Regeneron Pharmaceuticals, Inc. places H-1B workers across the United States
Cross-state DOL neighbors for Regeneron Pharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside NY.
Nearest cross-state employer filers by LCA filing count (713 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($153,437 here).
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-ELITE.
ABS(total_petitions) peer at 714 LCAs (Δ 1 heavier vs Regeneron Pharmaceuticals, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
ABS(total_petitions) peer at 715 LCAs (Δ 2 heavier vs Regeneron Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-ELITE vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
ABS(total_petitions) peer at 715 LCAs (Δ 2 heavier vs Regeneron Pharmaceuticals, Inc.); CERT-CLEAN · WAGE-PREMIUM vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
ABS(total_petitions) peer at 718 LCAs (Δ 5 heavier vs Regeneron Pharmaceuticals, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-ELITE.
NY pole at 6,144 LCAs stamps HEAVY-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Regeneron Pharmaceuticals, Inc.'s MID-BOOK.
Open the NY state board after the ABS peers. Regeneron Pharmaceuticals, Inc. stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Regeneron Pharmaceuticals, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Regeneron Pharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.